Cargando…
Clinical effectiveness of nimodipine for the prevention of poor outcome after aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis
OBJECTIVE: In clinical practice, nimodipine is used to control cerebral vasospasm (CVS), which is one of the major causes of severe disability and mortality in patients with aneurysmal subarachnoid hemorrhage (aSAH). However, the exact efficacy of nimodipine use for patients with aSAH is still contr...
Autores principales: | Hao, Guangzhi, Chu, Guangxin, Pan, Pengyu, Han, Yuwei, Ai, Yunzheng, Shi, Zuolin, Liang, Guobiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533126/ https://www.ncbi.nlm.nih.gov/pubmed/36212656 http://dx.doi.org/10.3389/fneur.2022.982498 |
Ejemplares similares
-
NEK7 Coordinates Rapid Neuroinflammation After Subarachnoid Hemorrhage in Mice
por: Li, Gen, et al.
Publicado: (2020) -
Safety and Clinical Effects of Switching From Intravenous to Oral Nimodipine Administration in Aneurysmal Subarachnoid Hemorrhage
por: Göttsche, Jennifer, et al.
Publicado: (2021) -
Adverse Events and Complications in Continuous Intra-arterial Nimodipine Infusion Therapy After Aneurysmal Subarachnoid Hemorrhage
por: Kapapa, Thomas, et al.
Publicado: (2022) -
Continuous Intraarterial Nimodipine Infusion for the Treatment of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: A Retrospective, Single-Center Cohort Trial
por: Kramer, Andreas, et al.
Publicado: (2022) -
Scoring Model to Predict Functional Outcome in Poor-Grade Aneurysmal Subarachnoid Hemorrhage
por: Shen, Jie, et al.
Publicado: (2021)